Peter G. Traber
2016 - Galectin Therapeutics
In 2016, Peter G. Traber earned a total compensation of $1M as Chief Executive Officer & President at Galectin Therapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Bonus | $160,877 |
|---|---|
| Option Awards | $288,136 |
| Salary | $512,500 |
| Other | $60,567 |
| Total | $1,022,080 |
Traber received $512.5K in salary, accounting for 50% of the total pay in 2016.
Traber also received $160.9K in bonus, $288.1K in option awards and $60.6K in other compensation.
Rankings
In 2016, Peter G. Traber's compensation ranked 8,154th out of 14,075 executives tracked by ExecPay. In other words, Traber earned more than 42.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,154 out of 14,075 | 42nd |
Division Manufacturing | 3,111 out of 5,486 | 43rd |
Major group Chemicals And Allied Products | 1,038 out of 1,900 | 45th |
Industry group Drugs | 807 out of 1,543 | 48th |
Industry Pharmaceutical Preparations | 638 out of 1,173 | 46th |
Source: SEC filing on November 7, 2017.
Traber's colleagues
We found two more compensation records of executives who worked with Peter G. Traber at Galectin Therapeutics in 2016.